ASCC Initiates Trials on Biomolecule Skin Cream

After receiving its first samples of Regenetech’s miraculously rejuvenating biomolecule skin cream last week, the Aristocrat Group Corp. (OTCBB: ASCC) announced today that it has initiated panel testing on the product to collect first hand testimonials for marketing.

Regenetech created the cream using NASA bioreactor technology developed for the space program. The device produces rejuvenating biomolecules as a byproduct of expanding, or multiplying, adult stem cells. These cytokines, peptides and proteins have been shown to dramatically reduce the appearance of wrinkles, age spots and sagging—results ASCC hopes to reproduce in our panel testing.

ASCC believes Regenetech’s skin-care line could be the key to capitalizing on the booming cosmetics market not only in the U.S., but across the globe. As the world’s population grows older, many predict that the market for anti-aging cosmetics could double.

“We’re particularly impressed with Regenetech’s product because it’s made using patented NASA technology, meaning it can’t be reproduced by competitors,” said ASCC CEO Cindy Morrissey. “We expect our market testing to confirm its desirability, and when it does, we plan to move forward with negotiations toward a definitive agreement.”

ASCC plans to expand its cosmetics business to compete in a highly profitable sector alongside Procter & Gamble (NYSE: PG), Unilever (NYSE: UL) and Avon Products, Inc. (NYSE: AVP).

Follow ASCC on Twitter at www.twitter.com/AristocratGroup.

About the Aristocrat Group

The Aristocrat Group Corp. (www.aristocratgroupcorp.com) is a women’s lifestyle company that aims to make the transition into parenthood smoother and more rewarding than ever before. Our smart growth initiatives will position us as the premier resource for prenatal and postpartum resources. For more information on our business plan, please visit www.aristocratgroupcorp.com/old/investor.html.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.